Background: Diethylcarbamazine citrate (DEC) is the drug most widely used in the treatment of lymphatic filariasis. Omega-3 fatty acids (ω -3 FAs) are essential polyunsaturated fatty acids and commonly found in marine oils. Both have been applied in treatment of inflammatory diseases but anti-allergic effects should be investigated.
Introduction
TMA, an acid anhydride widely used in the plastics industry, was successful to induce skin allergy in mice and rats through accumulation of eosinophils, mast cells and T cells. 1, 2 The skin, the largest organ of the human body, plays a critical role in the development of allergic diseases, such as atopic dermatitis. The epidermis also contains keratinocytes and Langerhans cells, a major dendritic cell of the skin that can acquire antigen. 3 DEC is the drug most widely used in the treatment of lymphatic filariasis since 1947. 4 DEC also has anti-inflammatory properties as a result of its interference with the arachidonic acid metabolism, which includes lipoxygenase and cyclooxygenase enzymes. 5 It was demonstrated that DEC has important role in blocking the pulmonary eosinophilic inflammation in mice sensitized with ovalbumin. 6 Nevertheless, the tropical application of DEC on Onchocerca-induced dermatitis could recruit large numbers of eosinophils and increase the expression of eotaxin. 7 The fish oil is rich in ω -3 FAs, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), could help to minimize the postshock inflammatory responses. These fatty acids have been reported to modulate inflammation and have been used clinically for that purpose. 8 These fatty acids have been already used for treatment of children atopic dermatitis because the metabolization of EPA and DHA could lead to dampening of skin inflammation.
In the current study, DEC and ω -3 FAs have been used to test their effects on TMA-induced skin allergy in albino white rat. The results indicated a more potent suppressing effect of ω-3 FAs than DEC.
Methods

Animals and Experimental Design
Twenty five female albino rats, weighing approximately 180-200 gm, were housed in an airconditioned room with a 12 h light/dark cycle. They were allowed free access to food and tap water. Rat sensitization, challenges with TMA and treatment were performed as previously described. 2 For the induction of skin hypersensitivity, rats were divided into five groups (5 each): control, TMA, DEC, ω-3 FAs and prednisolone (Pred) groups. All animal experiments were approved in accordance with the guidelines of the Beni-Suef University Laboratory Animal Management Committee.
Induction of allergic skin inflammation
Rats were sensitized with 50 μL of 5% TMA in solvent on shaved flank skin on day 0. Challenges with 10 μL of 5%TMA in solvent (acetone) on the dorsum of both ears were performed on day 5. Animals received challenges on the ears with 10 μL of 2% TMA in solvent on days 6-15. A solvent control group was exposed to acetone throughout the duration of the experiment. In the treatment groups, DEC (100 mg/kg B.W.), ω-3 FAs (0.6 g/ Kg B.W.) and Pred (positive control; 30 mg/kg B.W.) were administered orally 1 h before the challenges. Each of these doses was chosen according to previous reports and performed on days 9-15. 2, 12, 13 Ear thickness during the time course was determined with a custom-built micrometer (Schering AG, Germany).
At the end of the experiment, blood was taken and rats were killed by cervical dislocation. Three blood smears were made for each of the animals and allowed to air-dry. All slides were later stained with Wright's stain. A single blood smear was evaluated via light microscopy (Nikon Optiphod Transmitted Light Microscope) for each of five animals within the five groups under study. The purpose of the evaluation was to quantify each cell of the leukocyte species; namely lymphocytes, monocytes, neutrophils, basophils and eosinophils; counting up to one hundred leukocytes per slide in a total of three zones.
Ears were excised, minced and mechanically homogenized in phosphate buffer saline (pH 7.2) as 200 mg /ml, centrifuged at 25,000 g for 30 min at 4°C.
Nitrite assay
Nitrite concentration in the ear tissue homogenates was assayed by the Griess reaction.
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Nitrite concentration was calculated with reference to a standard curve obtained using NaNO 2 . Mean ± SD was calculated from four independent experiments.
Histological preparation and histochemical staining
Ear tissues were taken from different groups and fixed in 10% neutral buffer formalin for 24 hours, washed in tap water, dehydrated in serial dilutions of ethyl alcohol, cleared in xylene and embedded in paraffin. Tissue blocks were prepared for sectioning at 4 µm thicknesses by microtome, collected on glass slides, deparaffinized, stained by hematoxylin &eosin stain for routine examination then examination was done through the light electric microscope for histopathological studies.
Masson's trichrome was also used for demonstration of collagen fibers. 14 For mast cell detection, acidified toluidine blue (TB) staining was used to observe the occurrence of mast cells, their distribution and degranulation. 15 Carbol Chromotrope 2R (Sigma, St. Louis, USA)was used previously to identify eosinophils. 16 The mast cells and eosinophils of skin dermal region were counted per 10 high power fields (HPF) according to the classical method described.
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Immunohistochemistry using streptavidin biotin immunoperoxidase detection
The ear sections were processed for iNOS detection as previously described. 18 Rabbit anti-rat iNOS primary antibody was purchased from PharMingen (San Diego, CA), while biotinylated goat anti-rabbit antibody was purchased from Serotec (Oxford, UK).
Statistical analysis
Data were expressed as mean ± SEM for each group. One-way ANOVA with post hoc Dunnett's tests was used to test for significant difference between the rat groups. Analysis was performed by the usage of IBM SPSS statistics (Version 20, New York, USA).
Results
Effect of DEC and ω-3 FAs on TMA-induced increase in ear thickness
DEC and ω-3 FAs decreased ear thickness significantly (p < 0.05) at day 15 post challenge with TMA ( Figure 1 ). The positive control group indicated an obvious decrease (p < 0.01) compared to TMA group. The difference in thickness between the tested treatments and TMA started at day 12, while the difference between the positive control and TMA groups started at day 10.
Histopathological observations
There was normal histological appearance of ear epidermis and dermis in control group (Figure 2a) . In TMA treated group, focal haemorrhage was noticed with inflammatory cell infiltration in the dermal as well as in the musculature (Figure 2c ), while the deep layer of the dermis showed perivascular infiltration with inflammatory cells surrounding the severe dilated and congested blood vessels (Figure 2d ). The epidermal layers were disorganized with deeply stained pyknotic nuclei while some keratinocytes appeared shrunken with widening of intercellular spaces and proliferative response (Figure 2e ). In prednisolone-treated group which served as a positive control, histological structures of skin appeared normal (Figure 2b ). In ω-3 FAs group, most of the epidermal cells revealed their normal appearance with mild congestion in the blood vessels of the dermal layer (Figure 2f ). DEC revealed normal appearance for the epidermal cells, while the subcutaneous adipose tissue showed less inflammatory cell infiltration (Figure 2g ).
Effect of DEC and ω-3 FAs on TMA-induced eosinophil and mast cells accumulation
Induction of allergic skin using TMA could lead to an increase in blood eosinophilia (Figure 3a) . DEC and ω-3 FAs could show a significant decrease control group which showed few and slightly stained cells (Figure 4b ). Treatment with either ω-3 FAs or DEC revealed less number and slightly stained mast cells in the dermis (Figure 4e, f) . In the positive control group, eosinophils and mast cells did not appear in the skin tissue (Figure 3d and 4c, respectively).
Effect of DEC and ω-3 FAs on TMA-induced NO production and increased collagen fibers in the ear skin
Neither DEC nor ω-3 FAs did show a significant decreasing effect on the content of NO in skin tissue homogenates (Figure 5a ), while the positive control group (Pred) did show a significant (p < 0.05) decreasing effect. Immunohistochemical staining for iNOS in TMA group revealed an increased reaction in the form of fine brown granules (Figure 5d ) compared to weak reactions in the control groups (Figure 5b, c) . Treatment with ω-3 FAs revealed a decreased expression of iNOS (Figure 5e ), while DEC treatment indicated less obviously decreased expression (Figure 5f ).
In control group, blue-stained collagen fibers showed a normal appearance and arrangement. Below the basal lamina, collagen fiber aggregates were seen. They appeared as a network of more abundant and thick irregular bundles in the dermal layer (Figure 6a ). In TMA group, the content of collagen fibers increased and appeared as irregularly arranged dense bundles in both papillary and reticular layers of the dermis and around the hair follicles (Figure 6c ). Treatment with prednisolone and ω-3 FAs showed normal contents of collagen fibers (Figure 6b and d) , while DEC treatment showed less normal appearance (Figure 6e ).
Discussion
Inflammatory responses induced by TMA were evident by infiltration of the immune cells. In addition, the epidermal thickening was attributed to the TMA-induced proliferative response in the keratinocytes. This has also been observed using the mouse as a model. 2 DEC was less capable of reducing cell infiltration in skin tissue than ω-3 FAs. The mechanism of action for both DEC and ω-3 FAs on skin may be referred to the effective inhibition for lipoxygenase pathway and generation of regulatory T cells, respectively. 5, 19 In addition, the effect of ω-3 FAs to reverse skin histopathological alterations was compatible with previous reports about the need for essential fatty acids to improve cutaneous health. 20 In this study, we investigated if both DEC and ω-3 FAs could have a significant effect on allergic responses induced by TMA challenge in rat skin. From the results, it was apparent that both of DEC and ω-3 FAs could have a significantly depressing effect on blood and skin eosinophil count. This has also been observed previously in asthmatic children Omega-3 FAs were shown to increase apoptosis and decrease the eotaxin chemotactic effect in eosinophils. 22 DEC was found to have a suppressing effect on bone marrow eosinophil lineage, pulmonary eosinophil accumulation and IL-5-dependent eosinophilopoiesis. 6 DEC was also effective in inhibition of chronic hepatic inflammation induced by alcohol in mice. 23 Only treatment with ω-3 FAs was able to significantly decrease the number of mast cells compared to DEC. The decrease in purple color intensity in both of ω-3 FAs and DEC was attributed to decreased content of cytoblasmic granules and cell activity. 24 This may be related to the ability of both DEC and ω-3 FAs to change the content of cell fatty acids (including arachidonic acid) which are responsible for the release of inflammatory mediators. 25, 26 In mouse model of allergic skin induced by 2,4-dinitrofluorobenzene, ω-3 FAs derived mediator could reduce many of inflammatory responses like accumulation of mast cells, eosinophils and T cells in skin lesions. 27 In mammary tumor tissues, ω-3 FAs were found previously to decrease the mast cell infiltration. 28 This has been attributed to the suppressing effect of ω-3 FAs on Th2 cytokines by inhibiting of GATAs which are essential transcription factors for mast cell activation. 29 Treatment of human onchocerciasis by DEC could increase the mast cell infiltration and degranulation only after 1.5 hr posttreatment. 30 This may interpret the non-significant decrease of mast cell infiltration by DEC in our study. Increased content of densely arranged thick collagen fibers in the dermis of TMA-treated rats was associated with the increased numbers of mast cells. This can be explained by the fact that mast cells can affect the fibroblast functional behavior and, consequently, the fibrosis process, by releasing pre-formed mediatorssuch as histamine, proteoglycans, proteolytic enzymes and cytokines. 31 In addition, the density degree of stained fibers in both of ω-3 FAs and FAs showed normal contents of collagen fibers (e), while DEC treatment showed less normal collagen fibers (f). Scale bar represents 5μm.
DEC-treated groups were coincident with the observed mast cell numbers.
Monitoring of the ear thickness after TMA challenge indicated a decrease in positive control as well as treatment groups. The data of ear thickness represent strong evidence for the suppressing effect of DEC and ω-3 FAs on skin allergy with observable higher effectivity for the later. These data of ear thickness were compatible with those of infiltrated cells, however, ω-3 FAs did not reduce calve ear thickness in response to phytohemagglutinin-P. 32 DEC and ω-3 FAs decreased the levels of NO in skin, however, this effect was not significantly different compared to TMA group. In consistence, previous study on the effect of these fatty acids at lower concentrations on NO production from rat neutrophils did not show a significant effect. 33 DEC was previously shown to decrease the NO production due to its inhibitory effect on arachidonic acid metabolites which participate in NO production. 34 A significant and protective role of ω-3 FAs against NO sources like L-arginine and sodium nitroprusside were previously indicated. 35 In the current study, the nonsignificant effect of DEC and ω-3 FAs on NO in allergic skin may be referred to the different organ used and not other previously investigated tissues. In addition, higher concentrations might be needed to show a significant decrease. Investigation for expression of iNOS which is a precursor for NO synthesis revealed a decrease in immunostaining after treatment by both ω-3 FAs and DEC. However, the presence of stained foci in both sections may interpretate the non-significant effect in nitrite assay. This has also been observed in decreased mRNA expression of iNOS in rat liver after prefeeding with ω-3 FAs. 13 The slight appearance of thick collagen fibers in DEC group and its disappearance in ω-3 FAs treated group was related to the expression of iNOS in the skin tissue as previously described. 36 Dermal fibroblasts were found to produce NO as a result of stimulation with allergic metals. 37 NO has been identified as a modulator for mouse skin allergy because injection of its inhibitor could reduce the severity of contact hypersensitivity reaction. 38 The application of different allergens including TMA and 2,4-dinitrochlorobenzene indicated the increase in NO production from Langerhans cell and keratinocytes. 39, 40 The precise mode of action for NO in allergic reaction is still not clear but its increase is coincident with elevated allergic responses.
In conclusion, DEC was less effective than ω-3 FAs to reduce the TMA-induced allergy in the skin. This was apparent since DEC was not able to reduce NO production or mast cell infiltration in the skin. In addition, the histopathological investigation in the skin revealed still accumulated cells. However, DEC was effective to reduce blood and skin eosinophilia. Although DEC is effective inhibitor for arachidonic acid metabolism and suppressant for eosinophilopoiesis, its application in human allergic diseases is not advisable when compared to ω-3 FAs.
